Signals, Powered By EquityPandit
Natco Pharma has received the establishment inspection report (EIR) for its Kothur facility in Telangana from the US health regulator after successful completion of inspection.
The company has said in a BSE filing that Natco Pharma announces successful EIR from the US Food and Drug Administration (USFDA) for the inspection conducted at its drug manufacturing facility in Kothur village in Mahabubnagar district during January 16-24, 2017.
It added that “The Kothur facility predominantly caters to regulated international markets, including USA.”
